Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Basic & Clinical Pharmacology & Toxicology|April 2, 2014
At the centennial of Michaelis and Menten, competing Michaelis-Menten steps explain effect of GLP-1 on blood-brain transfer and metabolism of glucoseMichael Gejl, Jørgen Rungby, Birgitte Brock, et al.
Expert Opinion on Pharmacotherapy|July 21, 2010
Differences between long-acting insulins for the treatment of type 2 diabetesMichael Gejl Jensen, Mikkel Hansen, Birgitte Brock, et al.
Neuropharmacology|December 24, 2017
The effects of incretin hormones on cerebral glucose metabolism in health and diseaseMalin Nilsson, Albert Gjedde, Birgitte Brock, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 8, 2022
In Alzheimer's disease, amyloid beta accumulation is a protective mechanism that ultimately failsElise Brøchner Rischel, Michael Gejl, Birgitte Brock, et al.
International Journal of Cardiology|December 4, 2014
Risk of cardiovascular disease: the effects of diabetes and anti-diabetic drugs - a nested case-control studyMichael Gejl, Jakob Starup-Linde, Jan Scheel-Thomsen, et al.
Scientific Reports|December 14, 2017
Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog TreatmentMichael Gejl, Birgitte Brock, Lærke Egefjord, et al.
Reviews in Endocrine & Metabolic Disorders|June 10, 2014
Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisitedJan Hansen, Birgitte Brock, Hans Erik Bøtker, et al.
Frontiers in Pharmacology|December 20, 2016
Oral Administration of Sitagliptin Activates CREB and Is Neuroprotective in Murine Model of Brain TraumaBrian DellaValle, Gitte S Brix, Birgitte Brock, et al.
Ugeskrift for Laeger|December 19, 2009
[Life just is not fair - and statistics do not make it any better]Lars Folkestad, Michael Gejl Jensen, Mikkel Brabrand, et al.
Pageof 3